FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * Yu K Peony 2. Issuer Name and Ticker or Trading Symbol STAAR SURGICAL CO [ STAA ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)__X__ Director                    _____ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)         (First)         (Middle)
25651 ATLANTIC OCEAN DRIVE
3. Date of Earliest Transaction (MM/DD/YYYY)
1/21/2021
(Street)
LAKE FOREST, CA 
(City)       (State)       (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  1/21/2020  1/21/2020  A    318  A $0.00  318  D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Common Stock Options  $89.67  1/21/2021  1/21/2021  A        684   7/30/2021 (1) 1/20/2030  Common Stock  684  $0.00  684  D   

Explanation of Responses:
(1)  The options vest on the earlier of July 30, 2021 or the Corporation's 2021 Annual Shareholders Meeting.

Remarks:
Effective January 21, 2021, the Board of Directors appointed Dr. Yu to serve as a member of the Board and granted her, as a non-employee director, 684 options to purchase common stock, and 318 restricted shares, which represents a pro-rated amount of the standard director equity compensation for a director serving during the 2020-2021 term.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Yu K Peony
25651 ATLANTIC OCEAN DRIVE
LAKE FOREST, CA 
X



Signatures
/s/ Samuel Gesten as attorney-in-fact for Dr. K. Peony Yu. 1/26/2021
**Signature of Reporting Person Date